

Alcor Clinical Outsourcing Platform 20th and 21st September Boston USA
Days
Hours
Minutes
Seconds


Alcor Clinical Outsourcing Platform 18th and 19th October Prague, Czech Republic
Days
Hours
Minutes
Seconds
Alcor Clinical Outsourcing Platform 2023 intends to focus on global health and clinical trials around the world. Bioethics, regulations, patient recruitment, site selection, real-world data, data integration and strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, clinical auditing, and financial planning, as well as innovative sessions on new technologies The Alcor Clinical outsourcing Platform 2023 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. A broad range of people from the clinical trials community from around the world are participating in this multidisciplinary program to gain a deeper understanding of clinical research and clinical trials management.
During the last two decades, Pharma and Biotechnology companies have been constantly evolving, with new clinical studies, technologies, and advances in care and treatment enhancing efficiency while increasing the complexity of clinical trials, which require highly structured and coordinated testing. To address these issues, we need to look into innovative strategies, effective and quality collaborations, and new technologies that can cater to both patients’ and industry needs.
VP and Head of Clinical Operations, Adicet Bio
Chief Medical Officer, ASC Therapeutics
Associate Director, Clinical Data Management, Ascendis Pharma
VP, Business and Clinical Operations, Candel Therapeutics
Sr. Clinical Operations Professional, Imago BioSciences
Director, Clinical Operations, Iovance Therapeutics
Executive Director, Clinical Development Operations, MEI Pharma
Senior Vice President, Head of Development Operations and Inclusion, Diversity and Equity, Sana Biotechnology
Vice President of Clinical Development, AmMax Bio
Director, Clinical Operations, Patient Recruitment and Trial Management, Formerly Turning Point Therapeutics
Senior Director, CISCRP
Associate Director, BridgeBio
President, BioKier,
Director, Health Literacy, CISCRP
Director, Clinical Program Management , Bio-Path Holdings
Vice-Chair And Co-Founder, Marius Pharmaceuticals
Vice President, Head of Clinical Operations, Spring Works Therapeutics
Vice President, Clinical Operations & Procurement, Locus Biosciences
Sr VP Clinical Operations, Mana Therapeutics
Vice President, Clinical Affairs, NecteroMedical Inc
ABAC Therapeutics
CEO, Bryn Pharma
Associate Director, Clinical Data Management And Programming, Kronos Bio
Global Director Clinical Outsources Management, Grifols
Clinical Research Patient Engagement, DCRI
ABAC Therapeutics
Co Founder, Cloud Pharmaceuticals
Director Portfolio Management, Virpax Pharmaceuticals
Sr. Director, Clinical Operations, Precision Biosciences
Vice President, Drug Development, Alto Neuroscience
Executive Director, Clinical Operations, Terns Pharmaceuticals
M.A. Patient Inclusion and Health Equity, Chief Diversity Office, Genentech
Project Leader, Health Equity And Population Sciences, Hoffman La Roche
VP of Clinical Operations, CymaBay Therapeutics, Inc
Inclusive Research and Health Equity - gRED ECD Clinical Operations,Genentech
Consulting Dermatologist, Clinical Development & Medical Affairs RAPT Therapeutics, Inc.
Sr. Director, Clinical Operations NGM Bio
Director, Clinical Operations GSID
Vice President, Quality Iovance Biotherapeutics
President and CEO OrPro Therapeutics
Chief Executive Officer Certum Bio
Executive Director, Global Digital Quality Management Systems and Business Intelligence BeiGene
Executive Director, Global Medical Affairs Study Management, BioMarin Pharmaceuticals, Inc
CEO, SageMedic Corp
Host, Clinical Trial Podcast
Vice President Of Clinical, HeartFlow
Associate Director, Clinical Operations, Santen
Vice President, Program Management, Iovance Biotherapeutics
Vice President Of Clinical Affairs, Endogenex
Medical Director, Patient Safety Physician Digital & Devices, AstraZeneca
Executive Director, Clinical Outsourcing and Alliance Management, BridgeBio Pharma, Inc.
08:45 – 09:00 am Chairman’s Welcome Remarks
09:00 – 09:30 am Presentation 1
09:30 – 10:00 am Presentation 2
10:00 – 10:30 am Presentation 3
08:45 – 09:00 am Chairman’s Welcome Remarks
09:00 – 09:30 am Presentation 12
09:30 – 10:00 am Presentation 13
10:00 – 10:30 am Presentation 14
Schedule a meeting!